{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:43:40Z","timestamp":1770327820739,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Neumentum"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12325-023-02709-5","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T06:01:41Z","timestamp":1702101701000},"page":"659-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers"],"prefix":"10.1007","volume":"41","author":[{"suffix":"Jr.","given":"Joseph V.","family":"Pergolizzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanjot","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"issue":"2","key":"2709_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1089\/jpm.2019.0101","volume":"23","author":"ZS Sager","year":"2020","unstructured":"Sager ZS, Buss MK, Hill KP, Driver JA, Skarf LM. Managing opioid use disorder in the setting of a terminal disease: opportunities and challenges. J Palliat Med. 2020;23(2):296\u20139.","journal-title":"J Palliat Med"},{"issue":"5","key":"2709_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11916-018-0690-8","volume":"22","author":"S Mitra","year":"2018","unstructured":"Mitra S, Carlyle D, Kodumudi G, Kodumudi V, Vadivelu N. New advances in acute postoperative pain management. Curr Pain Headache Rep. 2018;22(5):35.","journal-title":"Curr Pain Headache Rep"},{"issue":"15","key":"2709_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624\u201345.","journal-title":"JAMA"},{"issue":"5","key":"2709_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.surg.2020.07.014","volume":"168","author":"MJ Best","year":"2020","unstructured":"Best MJ, McFarland EG, Anderson GF, Srikumaran U. The likely economic impact of fewer elective surgical procedures on US hospitals during the COVID-19 pandemic. Surgery. 2020;168(5):962\u20137.","journal-title":"Surgery"},{"key":"2709_CR5","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/JPR.S144066","volume":"10","author":"TJ Gan","year":"2017","unstructured":"Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017;10:2287\u201398.","journal-title":"J Pain Res"},{"issue":"40","key":"2709_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012484","volume":"97","author":"ML De Luca","year":"2018","unstructured":"De Luca ML, Ciccarello M, Martorana M, et al. Pain monitoring and management in a rehabilitation setting after total joint replacement. Medicine (Baltimore). 2018;97(40): e12484.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2709_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3113\/JSOA.2016.0002","volume":"25","author":"SC Mears","year":"2016","unstructured":"Mears SC, Edwards PK, Barnes CL. How to decrease length of hospital stay after total knee replacement. J Surg Orthop Adv. 2016;25(1):2\u20137.","journal-title":"J Surg Orthop Adv"},{"issue":"8","key":"2709_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.23736\/S0375-9393.19.13321-4","volume":"85","author":"JV Pergolizzi","year":"2019","unstructured":"Pergolizzi JV, Lequang JA, Passik S, Coluzzi F. Using opioid therapy for pain in clinically challenging situations: questions for clinicians. Minerva Anestesiol. 2019;85(8):899\u2013908.","journal-title":"Minerva Anestesiol"},{"issue":"6","key":"2709_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0009-9236(96)90210-6","volume":"60","author":"JW Mandema","year":"1996","unstructured":"Mandema JW, Stanski DR. Population pharmacodynamic model for ketorolac analgesia. Clin Pharmacol Ther. 1996;60(6):619\u201335.","journal-title":"Clin Pharmacol Ther"},{"key":"2709_CR10","unstructured":"Toradol (ketorolac tromethamine tablets) Nutley, New Jersey: Roche Pharmaceuticals, 1997. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/019645s019lbl.pdf."},{"key":"2709_CR11","unstructured":"Ketorolac tromethamine injection USP Lake Forest, Illinois: Hospira; 2011. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/074802s038lbl.pdf."},{"issue":"2","key":"2709_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.annemergmed.2016.10.014","volume":"70","author":"S Motov","year":"2017","unstructured":"Motov S, Yasavolian M, Likourezos A, et al. Comparison of intravenous ketorolac at three single-dose regimens for treating acute pain in the emergency department: a randomized controlled trial. Ann Emerg Med. 2017;70(2):177\u201384.","journal-title":"Ann Emerg Med"},{"key":"2709_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/acem.14202","volume":"28","author":"L Eidinejad","year":"2020","unstructured":"Eidinejad L, Bahreini M, Ahmadi A, Yazdchi M, Thiruganasambandamoorthy V, Mirfazaelian H. Comparison of intravenous ketorolac at three doses for treating renal colic in the emergency department: a noninferiority randomized controlled trial. Acad Emerg Med. 2020;28:768\u201375.","journal-title":"Acad Emerg Med"},{"issue":"6","key":"2709_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/00003088-199223060-00003","volume":"23","author":"DR Brocks","year":"1992","unstructured":"Brocks DR, Jamali F. Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet. 1992;23(6):415\u201327.","journal-title":"Clin Pharmacokinet"},{"issue":"6 Pt 2","key":"2709_CR15","first-page":"45s","volume":"10","author":"CR Brown","year":"1990","unstructured":"Brown CR, Mazzulla JP, Mok MS, Nussdorf RT, Rubin PD, Schwesinger WH. Comparison of repeat doses of intramuscular ketorolac tromethamine and morphine sulfate for analgesia after major surgery. Pharmacotherapy. 1990;10(6 Pt 2):45s\u201350s.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2709_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00003495-199753010-00012","volume":"53","author":"JC Gillis","year":"1997","unstructured":"Gillis JC, Brogden RN. Ketorolac: a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 1997;53(1):139\u201388.","journal-title":"Drugs"},{"issue":"9","key":"2709_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1517\/17425240903116006","volume":"6","author":"VR Sinha","year":"2009","unstructured":"Sinha VR, Kumar RV, Singh G. Ketorolac tromethamine formulations: an overview. Expert Opin Drug Deliv. 2009;6(9):961\u201375.","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02709-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02709-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02709-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T05:16:17Z","timestamp":1707023777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02709-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2709"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02709-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Pergolizzi is the chief research and development officer at Neumentum, Inc. Ms. Batra is a clinical research associate at Neumentum, Inc. Dr. Schmidt is a consultant to Neumentum, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethical approval was provided by the IntegReview institutional review board (IRB) in Austin, Texas. The study complied with the Good Clinical Practice requirements described in the current International Council for Harmonization (ICH) guidelines and current federal regulations. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}